Literature DB >> 8938604

Clinical applications of pharmacologic therapies for spinal cord injury.

S M Zeidman1, G S Ling, T B Ducker, R G Ellenbogen.   

Abstract

We review the evidence supporting the role of glucocorticosteroids, trilazad, and GM1 ganglioside in spinal cord injury and provide our critique of the published studies, along with our recommendations for pharmacologic therapy for this complex and difficult problem.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8938604

Source DB:  PubMed          Journal:  J Spinal Disord        ISSN： 0895-0385


  2 in total

1.  Neuroprotective effects of methylprednisolone and hypothermia after experimental spinal cord injury: a histopathological and stereological study.

Authors:  Bunyami Unal; Suleyman Kaplan; Ersan Odaci; Huseyin Aslan; Selina Aksak; Deniz Unal; B Zuhal Altunkaynak; Cemal Gundogdu; Ahmet Gokyar
Journal:  Eurasian J Med       Date:  2009-12

2.  The dual cyclooxygenase/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord.

Authors:  Jennifer N Dulin; Meredith L Moore; Raymond J Grill
Journal:  J Neurotrauma       Date:  2013-01-23       Impact factor: 5.269
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.